文献一覧
1.in situ Hybridization(文献数:16)
2.immunohistochemistry (文献数:65)
3.DNA microarray (文献数:8)
1. in situ Hybridization (文献数:16)
a: Discovery (9)
b: Benchmark (3)
c: Gen II(4)
1-a. in situ Hybridization ( Discovery)
“Morpho-Regulation of Ectodermal Organs: Integument Pathology and Phenotypic Variations in K14-Noggin Engineered Mice through Modulation of Bone Morphogenic Protein Pathway. “
Maksim Plikus, Wen Pin Wang, Jian Liu, Xia Wang, Ting-Xin Jiang, and Cheng-Ming Chuong
Am J Pathol 2004 164: 1099-1114.
“Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation.”
Suksaweang S, Lin CM, Jiang TX, Hughes MW, Widelitz RB, Chuong CM.
Dev Biol. 2004 Feb 1;266(1):109-122.
“ Application of automated mRNA in situ hybridization for formalin-fixed, paraffin-embedded mouse skin sections: effects of heat and enzyme pretreatment on mRNA signal detection. ”
Nitta H, K ishimoto J. and Grogan, TM. (2003).
Appl Immunohistochem Mol Morphol. 11 (2): 183-187.
“ Sculpting Skin Appendages Out of Epidermal Layers Via Temporally and Spatially Regulated Apoptotic Events ”
Chung-Hsing Chang, Mingke Yu, Ping Wu, Ting-Xin Jiang, Hsin-Su Yu, Randall B. Widelitz, and Cheng-Ming Chuong
J. Invest. Dermatol., Jun 2004; 122: 1348 - 1355.
“ The Petunia Ortholog of Arabidopsis SUPERMAN Plays a Distinct Role in Floral Organ Morphogenesis ”
Hitoshi Nakagawa, Silvia Ferrario, Gerco C. Angenent, Akira Kobayashi, and Hiroshi Takatsuji
PLANT CELL, Apr 2004; 16: 920 - 932.
“Role of petunia pMADS3 in determination of floral organ and meristem identity, as revealed by its loss of function”
Kapoor M., Tsuda S., Tanaka Y., Mayama T., Okuyama Y., Tsuchimoto S. and Takatsuji H.
The Plant Jornal, 2002; 32, 115-127.
“Silencing of the Tapetum-Specific Zinc Finger Gene TAZ1 Causes Premature Degeneration of Tapetum and Pollen Abortion in Petunia”
Kapoor S., Kobayashi A. and Takatsuji H.
The Plant Cell, 2002; 14, 2353-2367.
“Increased Expression of Iron-Regulation Genes in Monkey and Human Glaucom”
Farkas RH., Chowers I., Hackam AS., Kageyama M., Nickells RW., Otteson DC., Dub EJ. Wang C., Valenta DF., Gunatilaka TL., Pease ME., Quigley HA. and Zack DJ.
Invest. Ophthalmol. And Vis. Sci., 2004; 45, 1410-1417.
" Survival Analysis of Genome-Wide Gene Expression Profiles of Prostate Cancers Identifies New Prognostic Targets of Disease Relapse ”
Susan M. Henshall, Daniel E. H. Afar, Jordan Hiller, Lisa G. Horvath, David I. Quinn, Krishan K. Rasiah, Kurt Gish, Dorian Willhite, James G. Kench, Margaret Gardiner-Garden, Phillip D. Stricker, Howard I. Scher, John J. Grygiel, David B. Agus, David H. Mack, and Robert L. Sutherland
Cancer Res., Jul 2003; 63: 4196 - 4203.
1-b. in situ Hybridization ( Benchmark)
“Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application. ”
C Magro, AN Crowson, P Porcu, and GJ Nuovo
J Cutan Pathol, Sep 2003; 30(8): 504-11.
“Human Papillomavirus and Cervical Cancer ”
Eileen M. Burd
Clin. Microbiol. Rev., Jan 2003; 16: 1 - 17.
“The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy ”
Jeffrey S. Ross, Jonathan A. Fletcher, Gerald P. Linette, James Stec, Edward Clark, Mark Ayers, W. Fraser Symmans, Lajos Pusztai, and Kenneth J. Bloom
Oncologist, Aug 2003; 8: 307 - 325.
1-c. in situ Hybridization ( Gen II)
“Prostate Short-Chain Dehydrogenase Reductase 1 ( PSDR1 ): A New Member of the Short-Chain Steroid Dehydrogenase/Reductase Family Highly Expressed in Normal and Neoplastic Prostate Epithelium”
Lin B., White JT., Ferguson C., Wang S., Vessella R., Bumgarner R., True LD., Hood L. and Nelson PS.
Cancer Res., 2001; 61, 1611-1618.
“ Role of the Cdc25A phosphatase in human breast cancer. ”
Cangi MG, C. B., Soung P, Signoretti S, Moreira G Jr, Ranashinge M, Cady B, Pagano M, Loda M. (2000).
J Clin Invest 106 (6): 753-761 .
“ Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. ”
Reiter RE, G. Z., Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. (1998).
Proc Natl Acad Sci 95 (4): 1735-1740.
“Invasion Factors uPA/PAI-1 and HER2 status Provide Independent and Complementary Information on Patient Outcome in Node-Negative Breast Cancer”
Zemzoum I., Kates RE., Ross JS., Dettmar P., Dutta M., Henrichs C., Yurdseven S., Hofler H., Kiechle M., Schmitt M. and Harbeck N.
J. Clin. Oncol., 2003; 21, 1022-1028.
a: Discovery (6)
b: Benchmark (3)
c: NexES IHC (22)
d: ES (14)
e: Unknown Machine (20)
2-a. immunohistochemistry (Discovery)
“Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers .”
Manami Tanaka, T. T., Seiichiro Matsuzaki, Yasuhiro Seto, Taroh Matsuda, Kiyoshi Komori, Johbu Itoh, Hiroshi Kijima, Katsuyuki Tamai, Mayumi Shibayama, Yasunobu Hashimoto, Hideo Nakazawa, Hiroshi Toma (2003).
Med Sci Monit 9 (7): MT61-86.
“Phospho-Serine-118 Estrogen Receptor- Detection in Human Breast Tumors in Vivo”
Leigh Murphy, Tracy Cherlet, Adewale Adeyinka, Yulian Niu, Linda Snell, and Peter Watson
Clin. Cancer Res., Feb 2004; 10: 1354 - 1359.
“Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon Cancer: A Tissue Microarray Study”
Murray B. Resnick, Justin Routhier, Tamako Konkin, Edmond Sabo, and Victor E. Pricolo
Clin. Cancer Res., May 2004; 10: 3069 - 3075.
“Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction ”
Misako Sato, Yasuteru Muragaki, Shizuya Saika, Anita B. Roberts, and Akira Ooshima
J. Clin. Invest., Nov 2003; 112: 1486 - 1494.
“Transforming growth factor signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis ”
Peter M. Siegel, Weiping Shu, Robert D. Cardiff, William J. Muller, and Joan Massague
PNAS, Jul 2003; 100: 8430- 8435.
“Psoriasin Interacts with Jab1 and Influences Breast Cancer Progression ”
Ethan D. Emberley, Yulian Niu, Etienne Leygue, Ladislav Tomes, R. Daniel Gietz, Leigh C. Murphy, and Peter H. Watson
Cancer Res., Apr 2003; 63: 1954 - 1961.
2-b. immunohistochemistry (Benchmark)
“HER-2-Targeted Therapy: Lessons Learned and Future Directions ”
Rita Nahta and Francisco J. Esteva
Clin. Cancer Res., Nov 2003; 9: 5078- 5084.
“RAS Point Mutations and PAX8-PPAR Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma ”
Marina N. Nikiforova, Roy A. Lynch, Paul W. Biddinger, Erik K. Alexander, Gerald W. Dorn, II, Giovanni Tallini, Todd G. Kroll, and Yuri E. Nikiforov
J. Clin. Endocrinol. Metab., May 2003; 88: 2318- 2326.
“Invade or Proliferate? Two Contrasting Events in Malignant Behavior Governed by p16INK4a and an Intact Rb Pathway Illustrated by a Model System of Basal Cell Carcinoma ”
Sofie Svensson, Kristina Nilsson, Anita Ringberg, and Goran Landberg
Cancer Res., Apr 2003; 63: 1737 - 1742.
2-c. immunohistochemistry (NexES IHC)
“The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids ”
Andrew J. Brown, Susan M. Goldsworthy, Ashley A. Barnes, Michelle M. Eilert, Lili Tcheang, Dion Daniels, Alison I. Muir, Mark J. Wigglesworth, Ian Kinghorn, Neil J. Fraser, Nicholas B. Pike, Jay C. Strum, Klaudia M. Steplewski, Paul R. Murdock, Julie C. Holder, Fiona H. Marshall, Philip G. Szekeres, Shelagh Wilson, Diane M. Ignar, Steve M. Foord, Alan Wise, and Simon J. Dowell
J. Biol. Chem., Mar 2003; 278: 11312 - 11319.
“Altered Pattern of Major Histocompatibility Complex Expression in Renal Carcinoma: Tumor-Specific Expression of the Nonclassical Human Leukocyte Antigen-G Molecule Is Restricted to Clear Cell Carcinoma While Up-Regulation of Other Major Histocompatibility Complex Antigens Is Primarily Distributed in All Subtypes of Renal Carcinoma ”
El Cherif Ibrahim, Yves Allory, Frederic Commo, Bernard Gattegno, Patrice Callard, and Pascale Paul
Am. J. Pathol., Feb 2003; 162: 501 - 508.
“Erythropoietin and the Erythropoietin Receptor Are Expressed by Papillary Thyroid Carcinoma fromChildren and Adolescents.: Expression of Erythropoietin Receptor Might Be a Favorable Prognostic Indicator ”
Thomas G. Eccles, Aneeta Patel, Ajay Verma, Diarmuid Nicholson, Yvonne Lukes, R. Michael Tuttle, and Gary L. Francis
Ann. Clin. Lab. Sci., Oct 2003; 33: 411 - 422.
“Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer ”
Jacqueline S. Jeruss, Charles D. Sturgis, Alfred W. Rademaker, and Teresa K. Woodruff
Cancer Res., Jul 2003; 63: 3783 - 3790.
“β-Catenin Regulates Vascular Endothelial Growth Factor Expression in Colon Cancer ”
Vijay Easwaran, Sang H. Lee, Landon Inge, Lida Guo, Cheryl Goldbeck, Evelyn Garrett, Marion Wiesmann, Pablo D. Garcia, John H. Fuller, Vivien Chan, Filippo Randazzo, Robert Gundel, Robert S. Warren, Jaime Escobedo, Sharon L. Aukerman, Robert N. Taylor, and Wendy J. Fantl
Cancer Res., Jun 2003; 63: 3145 - 3153.
“Recipient T Cells Mediate Reperfusion Injury after Lung Transplantation in the Rat ”
Marc de Perrot, Kevin Young, Yumiko Imai, Mingyao Liu, Thomas K. Waddell, Stefan Fischer, Li Zhang, and Shaf Keshavjee
J. Immunol., Nov 2003; 171: 4995 - 5002.
“Comparison of Immunohistochemistry with Reverse Transcription-PCR for the Detection of Micrometastatic Prostate Cancer in Lymph Nodes ”
Shahrokh F. Shariat, Martine P. Roudier, George E. Wilcox, Michael W. Kattan, Peter T. Scardino, Robert L. Vessella, Sibel Erdamar, Cuong Nguyen, Thomas M. Wheeler, and Kevin M. Slawin
Cancer Res., Aug 2003; 63: 4662 - 4670.
“Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 ”
A. Vihola, G. Bassez, G. Meola, S. Zhang, H. Haapasalo, A. Paetau, E. Mancinelli, A. Rouche, J.Y. Hogrel, P. Laforet, T. Maisonobe, J.F. Pellissier, R. Krahe, B. Eymard, and B. Udd
Neurology, Jun 2003; 60: 1854 - 1857.
“The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids ”
Celia P. Briscoe, Mohammad Tadayyon, John L. Andrews, William G. Benson, Jon K. Chambers, Michelle M. Eilert, Catherine Ellis, Nabil A. Elshourbagy, Aaron S. Goetz, Dana T. Minnick, Paul R. Murdock, Howard R. Sauls, Jr., Usman Shabon, Lisa D. Spinage, Jay C. Strum, Philip G. Szekeres, Kong B. Tan, James M. Way, Diane M. Ignar, Shelagh Wilson, and Alison I. Muir
J. Biol. Chem., Mar 2003; 278: 11303 - 11311.
“Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis “
Yoshikatsu Kaneko, Minoru Sakatsume, Yuansheng Xie, Takeshi Kuroda, Michiko Igashima, Ichiei Narita, and Fumitake Gejyo
J. Immunol., Mar 2003; 170: 3377 - 3385.
Note: I don't know how, but it said use RTP-350 in spite of NexES IHC for staining.
“Molecular histogenesis of posttransplantation lymphoproliferative disorders ”
Daniela Capello, Michaela Cerri, Giuliana Muti, Eva Berra, Pierluigi Oreste, Clara Deambrogi, Davide Rossi, Giampietro Dotti, Annarita Conconi, Mario Vigano, Umberto Magrini, Giovanbattista Ippoliti, Enrica Morra, Annunziata Gloghini, Alessandro Rambaldi, Marco Paulli, Antonino Carbone, and Gianluca Gaidano
Blood, Nov 2003; 102: 3775-3785.
“Molecular Detection of Breast Cancer Cells in the Peripheral Blood of Advanced-Stage Breast Cancer Patients Using Multimarker Real-Time Reverse Transcription-Polymerase Chain Reaction and a Novel Porous Barrier Density Gradient Centrifugation Technology ”
Megan K. Baker, Kaidi Mikhitarian, Walid Osta, Kathi Callahan, Rana Hoda, Frank Brescia, Rayna Kneuper-Hall, Michael Mitas, David J. Cole, and William E. Gillanders
Clin. Cancer Res., Oct 2003; 9: 4865-4871.
“Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer ”
F Bataille, P Rummele, W Dietmaier, D Gaag, F Klebl, A Reichle, P Wild, F Hofstadter, and A Hartmann
Mol. Pathol., Oct 2003; 56: 286 - 292.
“ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases ”
Mihaela Onciu, Frederick G. Behm, James R. Downing, Sheila A. Shurtleff, Susana C. Raimondi, Zhigui Ma, Stephan W. Morris, Wren Kennedy, Sandra C. Jones, and John T. Sandlund
Blood, Oct 2003; 102: 2642-2644.
“STI571 Enhances the Therapeutic Index of Epothilone B by a Tumor-selective Increase of Drug Uptake ”
Kristian Pietras, Michael Stumm, Martine Hubert, Elisabeth Buchdunger, Kristofer Rubin, Carl-Henrik Heldin, Paul McSheehy, Markus Wartmann, and Arne Ostman
Clin. Cancer Res., Sep 2003; 9: 3779 - 3787.
“Sulfolipid Deficiency Does Not Affect the Virulence of Mycobacterium tuberculosis H37Rv in Mice and Guinea Pigs ”
Cecile Rousseau, Oliver C. Turner, Erik Rush, Yann Bordat, Tatiana D. Sirakova, Pappachan E. Kolattukudy, Shannon Ritter, Ian M. Orme, Brigitte Gicquel, and Mary Jackson
Infect. Immun., Aug 2003; 71: 4684-4690.
“Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer ”
Ethan D. Emberley, Yulian Niu, Catherine Njue, Erich V. Kliewer, Leigh C. Murphy, and Peter H. Watson
Clin. Cancer Res., Jul 2003; 9: 2627 - 2631.
“Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium ”
J F Miquel, M Moreno, L Amigo, H Molina, P Mardones, I I Wistuba, and A Rigotti
Gut, Jul 2003; 52: 1017 - 1024.
“The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis ”
Philip A. Marsden, Qin Ning, Laisum S. Fung, Xioping Luo, Yue Chen, Michael Mendicino, Anand Ghanekar, Jeremy A. Scott, Teresa Miller, Camie W.Y. Chan, Mathew W.C. Chan, Wei He, Reginald M. Gorczynski, David R. Grant, David A. Clark, M. James Phillips, and Gary A. Levy
J. Clin. Invest., Jul 2003; 112: 58 - 66.
“Noncultured, Autologous, Skeletal Muscle Cells Can Successfully Engraft Into Ovine Myocardium ”
Nicolas Borenstein, Patrick Bruneval, Mehrak Hekmati, Christophe Bovin;, Luc Behr, Christian Pinset, Francois Laborde, and Didier Montarras
Circulation, Jun 2003; 107: 3088 - 3092.
“ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile ”
Adrian Wiestner, Andreas Rosenwald, Todd S. Barry, George Wright, R. Eric Davis, Sarah E. Henrickson, Hong Zhao, Rachel E. Ibbotson, Jenny A. Orchard, Zadie Davis, Maryalice Stetler-Stevenson, Mark Raffeld, Diane C. Arthur, Gerald E. Marti, Wyndham H. Wilson, Terry J. Hamblin, David G. Oscier, and Louis M. Staudt
Blood, Jun 2003; 101: 4944-4951.
“CXCR4 expression in vitreoretinal membranes ”
L Cabay, F Willermain, C Bruyns, JM Verdebout, Y Witta, J Baffi, T Velu, J Libert, L Caspers-Velu, A Maho, and L Lespagnard
Br. J. Ophthalmol., May 2003; 87: 567 - 569.
2-d. immunohistochemistry (ES)
“Removal of mercuric chloride deposits from B5-fixed tissue will affect the performance of immunoperoxidase staining of selected antibodies”
X Wan, G Cochran, and TC Greiner
Appl Immunohistochem Mol Morphol, Mar 2003; 11(1): 92-5.
“Expression of the MAGE-A4 and NY-ESO-1 Cancer-Testis Antigens in Serous Ovarian Neoplasms ”
Evgeny Yakirevich, Edmond Sabo, Ofer Lavie, Salam Mazareb, Giulio C. Spagnoli, and Murray B. Resnick
Clin. Cancer Res., Dec 2003; 9: 6453 - 6460.
“Diffuse and intestinal type gastric carcinomas differ in their expression of apoptosis related proteins ”
C J van der Woude, J H Kleibeuker, A T G M Tiebosch, M Homan, A Beuving, P L M Jansen, and H Moshage
J. Clin. Pathol., Sep 2003; 56: 699 - 702.
“Pancreatic Carcinoma Surveillance in Patients With Familial Melanoma ”
Jana Foley Parker, Scott R. Florell, April Alexander, James A. DiSario, Paul J. Shami, and Sancy A. Leachman
Arch Dermatol, Aug 2003; 139: 1019 - 1025.
“Dysregulation of β-Catenin Expression Correlates With Tumor Differentiation in Pancreatic Duct Adenocarcinoma ”
Andrew M. Lowy, Cecilia Fenoglio-Preiser, On Ja Kim, Jennifer Kordich, Ana Gomez, Joy Knight, Laura James, and Joanna Groden
Ann. Surg. Oncol., Apr 2003; 10: 284-290.
“Effect of Lymphatic Mapping on the New Tumor-Node-Metastasis Classification for Colorectal Cancer ”
Anton J. Bilchik, Dean T. Nora, Leslie H. Sobin, Roderick R. Turner, Steven Trocha, David Krasne, and Donald L. Morton
J. Clin. Oncol., Feb 2003; 21: 668 - 672.
“The Absence of Mitochondrial Thioredoxin 2 Causes Massive Apoptosis, Exencephaly, and Early Embryonic Lethality in Homozygous Mice ”
Larisa Nonn, Ryan R. Williams, Robert P. Erickson, and Garth Powis
Mol. Cell. Biol., Feb 2003; 23: 916-922.
“Nuclear βcatenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong ”
S C C Wong, E S F Lo, A K C Chan, K C Lee, and W L Hsiao
Mol. Pathol., Dec 2003; 56: 347-352.
“Apoptosis Induction in Prostate Cancer Cells and Xenografts by Combined Treatment with Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand and CPT-11 ”
Subrata Ray and Alex Almasan
Cancer Res., Aug 2003; 63: 4713-4723.
“The Thioredoxin Redox Inhibitors 1-Methylpropyl 2-Imidazolyl Disulfide and Pleurotin Inhibit Hypoxia-induced Factor 1 and Vascular Endothelial Growth Factor Formation “
Sarah J. Welsh, Ryan R. Williams, Anne Birmingham, David J. Newman, D. Lynn Kirkpatrick, and Garth Powis
Mol. Cancer Ther., Mar 2003; 2: 235 - 243.
“Minimal focus of adenocarcinoma on prostate biopsy: clinicopathological correlations ”
X Leroy, S Aubert, A Villers, C Ballereau, D Augusto, and B Gosselin
J. Clin. Pathol., Mar 2003; 56: 230 - 232.
“NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors ”
Roberto Chiarle, Jerald Z. Gong, Ilaria Guasparri, Anna Pesci, Jonjing Cai, Jian Liu, William J. Simmons, Girish Dhall, Jennifer Howes, Roberto Piva, and Giorgio Inghirami
Blood, Mar 2003; 101: 1919-1927.
“Histology of Uterine Leiomyoma and Occurrence in Relation to Reproductive Activity in the Baltic Gray Seal (Halichoerus grypus) ”
B.-M. Backlin, L. Eriksson, and M. Olovsson
Vet. Pathol., Mar 2003; 40: 175-180.
“Immunopathogenesis of Pulmonary Granulomas in the Guinea Pig after Infection with Mycobacterium tuberculosis ”
Oliver C. Turner, Randall J. Basaraba, and Ian M. Orme
Infect. Immun., Feb 2003; 71: 864 - 871.
2-e. immunohistochemistry (Unknown Machine)
“Basal Cell Carcinoma With Pulmonary and Lymph Node Metastasis Causing Death ”
June K. Robinson and Madhu Dahiya
Arch Dermatol, May 2003; 139: 643-648.
“Elevated Expression of 12/15-Lipoxygenase and Cyclooxygenase-2 in a Transgenic Mouse Model of Prostate Carcinoma ”
Scott B. Shappell, Sandra J. Olson, S. Erin Hannah, Suzanne Manning, Richard L. Roberts, Naoya Masumori, Mitsuo Jisaka, William E. Boeglin, Virginia Vader, Dhiren S. Dave, M. Frances Shook, Tania Z. Thomas, Colin D. Funk, Alan R. Brash, and Robert J. Matusik
Cancer Res., May 2003; 63: 2256 - 2267.
“Developmental Expression of Magmas in Murine Tissues and Its Co-expression with the GM-CSF Receptor ”
Paul T. Jubinsky, Mary K. Short, George Mutema, and David P. Witte
J. Histochem. Cytochem., May 2003; 51: 585-596.
“Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal Chemotherapy ”
Andrew L. Feldman, Steven K. Libutti, James F. Pingpank, David L. Bartlett, Tatiana H. Beresnev, Sharon M. Mavroukakis, Seth M. Steinberg, David J. Liewehr, David E. Kleiner, and H. Richard Alexander
J. Clin. Oncol., Dec 2003; 21: 4560 - 4567.
“Peroxisome Proliferator-Activated Receptor Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity ”
Chris Baylis, Elke-Astrid Atzpodien, Gary Freshour, and Kevin Engels
J. Pharmacol. Exp. Ther., Dec 2003; 307: 854-860.
“Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis ”
Marcus Kremer, Leticia Quintanilla-Martinez, Margit Fuchs, Armando Gamboa-Dominguez, Sieglinde Haye, Holger Kalthoff, Erika Rosivatz, Christine Hermannstadter, Raymonde Busch, Heinz Hofler, and Birgit Luber
Carcinogenesis, Dec 2003; 24: 1879-1886.
“Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis ”
Lei Yao, Ombretta Salvucci, Adela R. Cardones, Sam T. Hwang, Yoshiyasu Aoki, Maria De La Luz Sierra, Agatha Sajewicz, Stefania Pittaluga, Robert Yarchoan, and Giovanna Tosato
Blood, Dec 2003; 102: 3900-3905.
“Epidermal Growth Factor Receptor in Non Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis ”
Fred R. Hirsch, Marileila Varella-Garcia, Paul A. Bunn, Jr, Michael V. Di Maria, Robert Veve, Roy M. Bremnes, Anna E. Baron, Chan Zeng, and Wilbur A. Franklin
J. Clin. Oncol., Oct 2003; 21: 3798 - 3807.
“Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer ”
Shashi R. Harvey, Thelma C. Hurd, Gabor Markus, Maisie I. Martinick, Remedios M. Penetrante, Dongfeng Tan, Preeti Venkataraman, Nisha DeSouza, Sheila N. J. Sait, Deborah L. Driscoll, and John F. Gibbs
Clin. Cancer Res., Oct 2003; 9: 4935-4943.
“Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer ”
G. Wiedswang, E. Borgen, R. Karesen, G. Kvalheim, J.M. Nesland, H. Qvist, E. Schlichting, T. Sauer, J. Janbu, T. Harbitz, and B. Naume
J. Clin. Oncol., Sep 2003; 21: 3469-3478.
“ The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation ”
Wulin Aerbajinai, Mara Giattina, Y. Terry Lee, Mark Raffeld, and Jeffery L. Miller
Blood, Jul 2003; 102: 712 - 717.
“ Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion ”
Dan Waisman, Vera Brod, Rafael Wolff, Edmond Sabo, Mark Chernin, Zalman Weintraub, Avi Rotschild, and Haim Bitterman
Am J Physiol Heart Circ Physiol, Jul 2003; 285: 643-652.
“ In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies ”
Ali Mahtabifard, Robert E. Merritt, Reiko E. Yamada, Ronald G. Crystal, and Robert J. Korst
J. Thorac. Cardiovasc. Surg., Jul 2003; 126: 28 - 38.
“ Highly effective treatment of acquired immunodeficiency syndrome related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology ”
Richard F. Little, Stefania Pittaluga, Nicole Grant, Seth M. Steinberg, Mark F. Kavlick, Hiroaki Mitsuya, Genoveffa Franchini, Martin Gutierrez, Mark Raffeld, Elaine S. Jaffe, Gene Shearer, Robert Yarchoan, and Wyndham H. Wilson
Blood, Jun 2003; 101: 4653 - 4659.
“ Rituximab plus CHOP (R-CHOP) overcomes bcl-2 associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) ”
Nicolas Mounier, Josette Briere, Christian Gisselbrecht, Jean-Francois Emile, Pierre Lederlin, Catherine Sebban, Francoise Berger, Andre Bosly, Pierre Morel, Herve Tilly, Reda Bouabdallah, Felix Reyes, Philippe Gaulard, and Bertrand Coiffier
Blood, Jun 2003; 101: 4279 - 4284.
“ Affinity Proteomics for Systematic Protein Profiling of Chromosome 21 Gene Products in Human Tissues ”
Charlotta Agaton, Joakim Galli, Ingmarie Hoiden Guthenberg, Lars Janzon, Marianne Hansson, Anna Asplund, Eva Brundell, Susanne Lindberg, Irene Ruthberg, Kenneth Wester, Dorothee Wurtz, Christer Hoog, Joakim Lundeberg, Stefan Stahl, Fredrik Ponten, and Mathias Uhlen
Mol. Cell. Proteomics, Jun 2003; 2: 405 - 414.
“ Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3) Pathway in Multiple Myeloma: Stat 3 Activation and Cyclin D1 Dysregulation Are Mutually Exclusive Events ”
Leticia Quintanilla-Martinez, Marcus Kremer, Katja Specht, Julia Calzada-Wack, Michaela Nathrath, Robert Schaich, Heinz Hofler, and Falko Fend
Am. J. Pathol., May 2003; 162: 1449 - 1461.
“ Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis ”
Leticia Quintanilla-Martinez, Theresa Davies-Hill, Falko Fend, Julia Calzada-Wack, Lynn Sorbara, Elias Campo, Elaine S. Jaffe, and Mark Raffeld
Blood, Apr 2003; 101: 3181 - 3187.
“ Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma ”
Christiane Copie-Bergman, Marie-Laure Boulland, Catherine Dehoulle, Peter Moller, Jean-Pierre Farcet, Martin J. S. Dyer, Corinne Haioun, Paul-Henri Romeo, Philippe Gaulard, and Karen Leroy
Blood, Apr 2003; 101: 2756-2761.
“ cDNA Microarray Analysis of Macroregenerative and Dysplastic Nodules in End-Stage Hepatitis C Virus-Induced Cirrhosis ”
Robert A. Anders, Lisa M. Yerian, Maria Tretiakova, Jon M. Davison, Richard J. Quigg, Peter H. Domer, Jamie Hoberg, and John Hart
Am. J. Pathol., Mar 2003; 162: 991 - 1000.
3. DNA microarray (Discovery)
“ Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome”
Toni Whistler, Elizabeth R Unger, Rosane Nisenbaum and Suzanne D Vernon
Journal of Translational Medicine 2003, 1:10.
“Molecular Quality of Exfoliated Cervical Cells: Implications for Molecular Epidemiology and Biomarker Discovery”
Angelique H. Habis, Suzanne D. Vernon, Daisy R. Lee, Mukesh Verma, and Elizabeth R. Unger
Cancer Epidemiol Biomarkers Prev 2004;13(3). March 2004.
“Screening anti-inflammatory compounds in injured spinal cord with microarrays: A comparison of bioinformatics analysis approaches.”
Jonathan Z. Pan, Rebecka Jornsten and Ronald P. Hart (2004).
Physiol Genomics. 2004 Feb 17.
“Mediators of ischemic preconditioning identified by microarray analysis of rat spinal cord.”
Jason B. Carmel, Ruben Mestril, Wise Young, R. P. Hart, Martin Marsala (2003).
Exp Neurol. 2004 Jan;185(1):81-96.
“In Vivo Pharmacokinetics and Regulation of Gene Expression Profiles by Isothiocyanate Sulforaphane in the Rat”
Rong Hu, Vidya Hebbar, Bok-Ryang Kim, Chi Chen, Bozena Winnik, Brian Buckley, Patricia Soteropoulos, Peter Tolias, Ronald P. Hart, and A.-N. Tony Kong
J. Pharmacol. Exp. Ther., Jul 2004; 310: 263 - 271.
“Comparison of fluorescence and resonance light scattering for highly sensitive microarray detection of bacterial pathogens.”
Francois P, Bento M, Vaudaux P, Schrenzel J.
J Microbiol Methods. 2003 Dec;55(3):755-762.
“ Impact of RNA extraction from limited samples on microarray results. ”
Ojaniemi H, E. B., Lee DR, Unger ER, Vernon SD (2003).
Biotechniques 35 (5): 968-973.
“Dendrimeric coating of glass slides for sensitive DNA microarrays analysis”
Berre VL., Trevisiol E., Dagkessamanskaia A., Sokol S., Caminade AM., Majoral JP., Meunier B. and Francois J.
Nucleic Acids Res., 2003; 31,
TD事業部お問い合せ
ロシュ・ダイアグノスティックス株式会社TD事業部
〒105-0014 東京都港区芝2-6-1
電話: 電話 03-5443-6670(代表)
電話: 電話 03-5443-7177
電話: 電話 0120-868-555(カスタマーサポートセンター)
Fax: fax 03-5443-7120(代表)
Fax: fax 0120-822-770(カスタマーサポートセンター)
受付時間:月曜日から金曜日(祝祭日、年末年始を除く)9時00分から18時00分まで
